The Future of Medicine: CRISPR, Genomics & What’s Next | Dr. Mohammed Dafil
Join Dr. Mohammed Dafil, Founder & CEO of GenomeArc, as he takes the stage at the Dubai Future Foundation to explore the groundbreaking future of genomics, CRISPR, and the rapidly evolving field of precision medicine.
In this thought-provoking conversation, unpacks the transformative power of genomic technologies—from editing DNA with CRISPR to decoding the human genome at scale. With these advancements, we're no longer just treating disease—we're on the brink of preventing it, personalizing treatment, and potentially redefining what it means to be human.
www.genomearc.com
Email: [email protected]
P.S. This video of Dr. Mohammed Dafil taken from Dubai Future Foundation docuseries.
GenomeArc Inc. is a biotech company on clinical genetics and drug discovery headquartered in Mississauga, Ontario. The company began its journey in 2021, GenomeArc develops artificial intelligence integrated solutions for genetic diagnosis and genomic drug development solutions for rare genetic disorders and pan cancer. As a research-oriented biotech company, GenomeArc brings new insights into rare diseases, cancer diagnosis, and therapeutics through genome analysis. The GenomeArc team is constantly innovating technologies to solve phenotypic complexities in genetic variations for rapid intervention. As a global company, our aim is to make efficient and accurate genome medicine technologies accessible for all healthcare systems.
#Genomics #CRISPR #GenomeArc #MohammedDafil #DubaiFutureFoundation #FutureOfMedicine #Biotech #PrecisionMedicine #DNA #GeneticEngineering #Innovation #Science #cancer #cancergenome #tumor #genes #genomics